Bruker Corporation reported its financial results for the second quarter of 2026, revealing total revenue of $838.5 million, a 5.2% increase from $797.4 million in the same period last year. The company's product revenue rose to $663.7 million, up from $634.7 million, while service and other revenue also saw an increase to $174.8 million from $162.7 million. However, the company experienced a consolidated net loss of $50.9 million, compared to a net income of $4.2 million in the prior year, primarily due to significant goodwill impairment charges totaling $134.9 million.

In terms of operational changes, Bruker completed several acquisitions during the first half of 2026, including the acquisition of Tofwerk AG, which enhances its mass spectrometry portfolio. The company also underwent a reorganization of its reportable segments, effective in the third quarter of 2026, aimed at improving decision-making and customer focus. This restructuring will result in the formation of new segments, including BSI Biosystems and BSI Microbiology and Infection Diagnostics, although it did not impact the financial results for the quarter ended June 30, 2026.

Geographically, revenue growth was observed in North America and Europe, with increases of 10.7% and 13.3%, respectively, while revenue from the Asia Pacific region decreased by 10.2%. The company reported a gross profit of $416.0 million, representing a gross profit margin of 49.6%, an improvement from 44.9% in the previous year. This increase was attributed to cost-saving initiatives and favorable revenue mix, despite facing foreign exchange headwinds.

Bruker’s total assets decreased to $6.05 billion as of June 30, 2026, down from $6.24 billion at the end of 2025. The company’s cash and cash equivalents also declined to $184.9 million from $298.8 million. The company anticipates that its existing cash and credit facilities will be sufficient to support its operating and investing needs for the foreseeable future. Looking ahead, Bruker expects to continue navigating challenges related to market conditions and supply chain dynamics while focusing on strategic growth initiatives and operational efficiencies.

About BRUKER CORP

Bruker Corporation develops, manufactures, and distributes high-performance scientific instruments and analytical solutions for life and materials science research, biopharmaceuticals, diagnostics, and applied markets. Its core technologies include magnetic resonance, mass spectrometry, chromatography, X-ray, microscopy, and molecular spectroscopy. Serving academic, government, industrial, and clinical customers worldwide, Bruker offers integrated hardware, software, and services that enable molecular and cellular analysis, supporting innovation and productivity across diverse scientific fields.

This description was generated via AI from an annual report. Updated about 1 year ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.

View the complete official filing on the SEC website.

Read on SEC.gov